Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis

Archives of Gynecology and Obstetrics

Volumn 285, Issue 1, 2012, Pages 215-221

  Ren, Fang ^a   Wang, Danbo ^a   Jiang, Yanduo ^b   Ren, Fengyan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b No 202 Hospital of PLA   (China)

Author keywords

Endometriosis; Eutopic endometria; HMLH1; Hypermethylation; Malignant transformation

Indexed keywords

PROTEIN MLH1; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; ECTOPIC ENDOMETRIA; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; ENDOMETRIOSIS ASSOCIATED OVARIAN CARCINOMA; ENDOMETRIUM; EPIGENETICS; EUTOPIC ENDOMETRIA; FEMALE; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALIGNANT TRANSFORMATION; OVARY CARCINOMA; OVARY ENDOMETRIOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; TISSUE SECTION; CARCINOMA; CELL TRANSFORMATION; DNA METHYLATION; GENE SILENCING; GENETICS; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; ENDOMETRIOSIS; FEMALE; GENE SILENCING; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84860790124     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1922-x     Document Type: Article

References (24)

1. Noel JC, Chapron C, Fayt I et al (2008) Lymph node involvement and lympho -vascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 89(5):1069-1072
2. Anaf V, El Nakadi I, Simon P et al (2004) Preferential infiltration of large bowel endometriosis along the nerves of the colon. Hum Reprod 19(4):996-1002
3. Sampson JA (1925) Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 10:1-72
4. Obata K, Hoshiai H (2000) Common genetic changes between endometriosis and ovarian cancer. Gynecol Obstet Invest 50(Suppl 1):39-43
5. OK Fukunaga M, Nomura K, Ishikawa E et al (1997) Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30:249-255
6. OK Seidman JD (1996) Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 115:2-9
7. OK Guan H, Ji M, Hou P et al (2008) Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 113(2):247-255
8. OK Leung SY, Yuen ST, Chung LP et al (1999) hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59:159-164
9. OK Amemiya S, Sekizawa A, Otsuka J et al (2004) Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability. Int J Gynaecol Obstet 86(3):371-376
10. OK Ali-Fehmi R, Khalifeh I, Bandyopadhyay S et al (2006) Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. J Int J Gynecol Pathol 25(3):223-229
11. OK Salvesen HB, MacDonald N, Ryan A et al (2000) Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 6(9):3607-3613
12. OK Geisler JP, Goodheart MJ, Sood AK et al (2003) Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98(10):2199-2206
13. OK Scott RB (1953) Malignant changes in endometriosis. J Obstet Gynecol 2:283-289
14. OK Herman JG, Graff JR, Myöhänen S et al (1996) Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
15. OK Ercoli A, Ferrandina G, Genuardi M et al (2005) Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer. Int J Gynecol Cancer 15(2):308-311
16. OK Martini M, Ciccarone M, Garganese G et al (2002) Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 102:398-406
17. OK Xu B, Hamada S, Kusuki I et al (2011) Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. Gynecol Oncol 120(2):239-246
18. OK Dinulescu DM, Ince TA, Quade BJ et al (2005) Role of K-ras and Pten in the 6 development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11(1):63-70
19. OK Zanetta GM, Webb MJ, Li H et al (2000) Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 79:18-22
20. OK Noel JC, Anaf V, Fayt I et al (2006) Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation. Arch Gynecol Obstet 274(6):389-392
21. OK Saylam K, Devreker F, Simon P et al (2006) Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations. Acta Obstet Gynecol Scand 85(12):1506-1507
22. Van Gorp T, Amant F, Neven P et al (2004) Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 18(2):349-371
23. Furlan D, Carnevali I, Marcomini B et al (2006) The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Clin Cancer Res 12(11):3329-3336
24. OK Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J et al (2008) Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14(1):32-40